ipilimumab,cdactin,nivolumab
miyarisan,osel,bms
['nivo', 'ipilimumab', 'nivolumab', 'cbm588', 'rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', '/ipi']
looking forward to #asco23 poster presentation by - assessment of short-chain fatty acid (scfa) and circulating cytokine trends in a clinical trial of nivolumab/ipilimumab and cbm588 in metastatic renal cell carcinoma #mrcc 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology